AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list Getty What you eat can affect your prostate health, for better or worse.

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Most men don’t prefer to go for routine screenings for prostate cancer due to fear and embarrassment. There are also myths ...

As men age, various health concerns become more prevalent, particularly those related to prostate health. One of the most common issues faced by older men is an enlarged prostate, which can lead to ...

CHICAGO (Reuters) - Prostate cancer screening is not likely to benefit men over age 75 and is not recommended for them while more evidence is needed to determine whether younger men benefit from early ...